Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 8:15 AM GMTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Africa to get BioNTech mRNA vaccine factory soon Ruchika Sharma12 Jun 2022 3:30 AM GMTBioNTech has said the BioNTainers could make other mRNA vaccines against malaria or tuberculosis, depending on product development progress and future...
Pfizer third COVID vaccine shot over 80 percent effective against Omicron in kids under 5 MD Bureau24 May 2022 10:25 AM GMTStudies in adults, adolescents, and children over 5 years of age continue to indicate that three doses of the Pfizer-BioNTech COVID-19 Vaccine...
Pfizer-BioNTech COVID booster shot gets USFDA emergency use nod for children aged 5 to 11 Ruchika Sharma18 May 2022 6:18 AM GMTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Health Bulletin 17/May/2022 Isra Zaman17 May 2022 11:10 AM GMTHere are the top health stories for the day: Entry level Ayush NABH certificates given to 5 Ayurveda Hospitals Ministry of Ayush has...
USFDA to soon authorize Pfizer COVID booster shot for children aged 5 to 11: NYT Ruchika Sharma17 May 2022 5:30 AM GMTThey have cited data from a mid- to late-stage study showing a third dose of their shot increased protection against the original coronavirus version...
COVID vaccine makers shift focus to booster shots Ruchika Sharma10 May 2022 5:30 AM GMTPfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...
BioNTech posts tripled Q1 vaccine sales but still flags full-year decline Ruchika Sharma10 May 2022 3:45 AM GMTBioNTech reiterated its 2022 vaccine revenue guidance of between 13 billion and 17 billion euros, down from 19 billion last year, implying a decline...
Pfizer keeps coronavirus sales forecast unchanged as pandemic curbs ease Ruchika Sharma5 May 2022 4:30 AM GMTThe company's reluctance to lift that forecast could signal a dearth of new sales contracts for the drug during the first quarter.
Pfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 years Ruchika Sharma28 April 2022 9:52 AM GMTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (USFDA) for Emergency Use Authorization...
Pfizer to seek USFDA nod for COVID booster for healthy 5- to 11-year-olds Ruchika Sharma17 April 2022 4:15 AM GMTThe Pfizer shots are the only vaccine available to US children.
BioNTech COVID vaccine causes deafness: WHO Isra Zaman5 April 2022 9:28 AM GMTAccording to a VigiBase report from WHO, instances of auditory loss also referred to as tinnitus was observed in people who were given Covid-19...
